Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • mhayes
    Member
    • Aug 2011
    • 11

    #1

    Clarification on interchromosomal event annotations

    Hi,

    I am not sure if this is the correct forum for this question, so I apologize in advance.

    When I see interchromosomal rearrangements (e.g. translocations) annotated in databases and publications, the following information is usually given:

    chrA, chrA breakpoint, strand A, chrB, chrB breakpoint, strand B

    The participating chromosomes are provided as well as the breakpoints. The strands that form the translocation are also provided.

    My question is, for a given rearrangement, does it matter which chromosome is annotated as chrA or chrB? Since these are interchromosomal events, I assume there is no inherent ordering among the participating chromosomes. Is it customary to just arbitrarily assign one of the participating chromosomes as the "beginning" of the rearrangement?

    Also, let's say we have the following fusion between the plus strands of chromosomes 3 and 4:

    chr3, 323246186, +, chr4, 118501916, +

    Couldn't I also annotate this as shown below?

    chr4, 118501916, -, chr3, 323246186, -

    Thanks.

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
26 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Working...